News

What's new at Łukasiewicz – PORT?

Disruptions in energy metabolism are increasingly linked to the development of neurodegenerative diseases. Research by Dr. Ismail Gbadamosi shows how TDP-43 and energy imbalance influence motor neuron vulnerability in ALS, opening the way to new therapeutic strategies.
Dr. Andrii Domanskyi, a neurobiologist with years of academic and industry experience, will discuss chronic pain research on April 16 at 2:00 PM in the Main Hall of Łukasiewicz – PORT.
Project selection procedures, Poland’s innovation convergence with the EU, and plans for a Shared Services Center were the key topics discussed at the March 20 meeting of the Łukasiewicz Research Network Directors in Wrocław.
Can cancer cells exploit strategies known from parasite biology? Dr. Marek Wagner explores melanoma from an evolutionary perspective, highlighting how tumors may manipulate the immune system in ways reminiscent of parasites.
Leading scientists, clinicians, industry representatives, working at the intersection of oncology, neuroscience, and precision medicine will meet at Łukasiewicz – PORT on May 28–29, 2026.
For more than a century, science believed that neurons were responsible for our thoughts, emotions, and memory. During Brain Awareness Week, we tell the story of astrocytes.
grupa-badawcza-immunoterapii-badania-glejak
Glioblastoma is one of the most formidable challenges in modern oncology—a cancer that often evades both conventional treatments and advanced immunotherapies. In the SelCell project, scientists at the Łukasiewicz – PORT are exploring a new strategy based on gamma-delta T lymphocytes. Their goal is to understand why immune cells from some donors can destroy tumor cells far more effectively than those from others.
The WABIO Project has secured over PLN 7 million under the TEAM NET program to develop and validate an integrated biorefinery prototype within the consortium. The work at Łukasiewicz will be led by Prof. Andrzej Białowiec.
We invite you to join a free webinar titled “European Innovation Pathways in Health: Opportunities for MedTech and Biotech Companies,” dedicated to growth and funding opportunities for companies operating in the medical technology and biotechnology sectors.
On February 24, at the headquarters of the Foundation for Polish Science, we officially launched the implementation of the International Research Agendas (MAB) project within the P4Health Center of Excellence.
[ninja_form id=17]

This will close in 0 seconds

This will close in 0 seconds